These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2154990)

  • 21. Quinolones share a common interaction domain on topoisomerase II with other DNA cleavage-enhancing antineoplastic drugs.
    Elsea SH; Westergaard M; Burden DA; Lomenick JP; Osheroff N
    Biochemistry; 1997 Mar; 36(10):2919-24. PubMed ID: 9062121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of two distamycin-ellipticine hybrid molecules on topoisomerase I and II mediated DNA cleavage: relation to cytotoxicity.
    Riou JF; Grondard L; Naudin A; Bailly C
    Biochem Pharmacol; 1995 Jul; 50(3):424-8. PubMed ID: 7646545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of topoisomerase II-targeted drugs on enzyme-mediated DNA cleavage and ATP hydrolysis: evidence for distinct drug interaction domains on topoisomerase II.
    Robinson MJ; Corbett AH; Osheroff N
    Biochemistry; 1993 Apr; 32(14):3638-43. PubMed ID: 8385484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conformational properties of topoisomerase II inhibitors and sequence specificity of DNA cleavage.
    Palumbo M; Mabilia M; Pozzan A; Capranico G; Tinelli S; Zunino F
    J Mol Recognit; 1994 Sep; 7(3):227-31. PubMed ID: 7880548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of amsacrine and epipodophyllotoxins on topoisomerase II cleavage in the human c-myc protooncogene.
    Pommier Y; Orr A; Kohn KW; Riou JF
    Cancer Res; 1992 Jun; 52(11):3125-30. PubMed ID: 1317259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of eukaryotic topoisomerase II cleavage sites in the presence of the quinolone CP-115,953 reveals drug-dependent and -independent recognition elements.
    Spitzner JR; Chung IK; Gootz TD; McGuirk PR; Muller MT
    Mol Pharmacol; 1995 Aug; 48(2):238-49. PubMed ID: 7651357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and structure-activity relationship of methyl-substituted indolo[2,3-b]quinolines: novel cytotoxic, DNA topoisomerase II inhibitors.
    Peczyńska-Czoch W; Pognan F; Kaczmarek L; Boratyński J
    J Med Chem; 1994 Oct; 37(21):3503-10. PubMed ID: 7932579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and evaluation of novel ellipticines as potential anti-cancer agents.
    Deane FM; O'Sullivan EC; Maguire AR; Gilbert J; Sakoff JA; McCluskey A; McCarthy FO
    Org Biomol Chem; 2013 Feb; 11(8):1334-44. PubMed ID: 23314103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of topoisomerase II-mediated DNA cleavage by a protoberberine alkaloid, berberrubine.
    Kim SA; Kwon Y; Kim JH; Muller MT; Chung IK
    Biochemistry; 1998 Nov; 37(46):16316-24. PubMed ID: 9819224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between topoisomerase II and radiosensitivity in mouse L5178Y lymphoma strains.
    Evans HH; Ricanati M; Horng MF; Mencl J
    Mutat Res; 1989 Jan; 217(1):53-63. PubMed ID: 2536134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced DNA topoisomerase II activity and drug-stimulated DNA cleavage in 9-hydroxyellipticine resistant cells.
    Charcosset JY; Saucier JM; Jacquemin-Sablon A
    Biochem Pharmacol; 1988 Jun; 37(11):2145-9. PubMed ID: 2837227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design of two etoposide-amsacrine conjugates: topoisomerase II and tubuline polymerization inhibition and relation to cytotoxicity.
    Arimondo P; Boukarim C; Bailly C; Dauzonne D; Monneret C
    Anticancer Drug Des; 2000 Dec; 15(6):413-21. PubMed ID: 11716434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1-Amino-substituted 4-methyl-5H-pyrido[4,3-b]indoles (gamma-carbolines) as tricyclic analogues of ellipticines: a new class of antineoplastic agents.
    Bisagni E; Nguyen CH; Pierré A; Pépin O; de Cointet P; Gros P
    J Med Chem; 1988 Feb; 31(2):398-405. PubMed ID: 3339609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of topoisomerase II beta in the resistance of 9-OH-ellipticine-resistant Chinese hamster fibroblasts to topoisomerase II inhibitors.
    Dereuddre S; Delaporte C; Jacquemin-Sablon A
    Cancer Res; 1997 Oct; 57(19):4301-8. PubMed ID: 9331091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of human DNA topoisomerase IIα by two novel ellipticine derivatives.
    Vann KR; Ergün Y; Zencir S; Oncuoglu S; Osheroff N; Topcu Z
    Bioorg Med Chem Lett; 2016 Apr; 26(7):1809-12. PubMed ID: 26906637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cytotoxicity and interaction of amsacrine derivatives with topoisomerase II: role of the 1' substitute on the aniline nucleus].
    René B; Fossé P; Khélifa T; Jacquemin-Sablon A; Bailly C
    Bull Cancer; 1997 Oct; 84(10):941-8. PubMed ID: 9435795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Similar sequence specificity of mitoxantrone and VM-26 stimulation of in vitro DNA cleavage by mammalian DNA topoisomerase II.
    Capranico G; De Isabella P; Tinelli S; Bigioni M; Zunino F
    Biochemistry; 1993 Mar; 32(12):3038-46. PubMed ID: 8384486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo and in vitro stimulation by antitumor drugs of the topoisomerase II-induced cleavage sites in c-myc proto-oncogene.
    Riou JF; Vilarem MJ; Larsen CJ; Multon E; Riou GF
    NCI Monogr; 1987; (4):41-7. PubMed ID: 2819730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Position-specific effects of base mismatch on mammalian topoisomerase II DNA cleaving activity.
    Bigioni M; Zunino F; Tinelli S; Austin CA; Willmore E; Capranico G
    Biochemistry; 1996 Jan; 35(1):153-9. PubMed ID: 8555169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transfection of 9-hydroxyellipticine-resistant Chinese hamster fibroblasts with human topoisomerase IIalpha cDNA: selective restoration of the sensitivity to DNA religation inhibitors.
    Khélifa T; René B; Le Mée S; Lambert B; Saucier JM; Markovits J; Jacquemin-Sablon H; Jacquemin-Sablon A
    Cancer Res; 1999 Oct; 59(19):4927-36. PubMed ID: 10519406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.